Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
35,140,515
-
Share change
-
-60,600,002
-
Total reported value
-
$4,000,234
-
Put/Call ratio
-
148%
-
Price per share
-
$0.11
-
Number of holders
-
67
-
Value change
-
-$34,845,040
-
Number of buys
-
23
-
Number of sells
-
85
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q4 2018
As of 31 Dec 2018,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,140,515 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Vanguard Group Inc, NORTHERN TRUST CORP, Jefferies Group LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and CITIGROUP INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.